1. Home
  2. MDGL vs POST Comparison

MDGL vs POST Comparison

Compare MDGL & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • POST
  • Stock Information
  • Founded
  • MDGL 2011
  • POST 1895
  • Country
  • MDGL United States
  • POST United States
  • Employees
  • MDGL N/A
  • POST N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • POST Packaged Foods
  • Sector
  • MDGL Health Care
  • POST Consumer Staples
  • Exchange
  • MDGL Nasdaq
  • POST Nasdaq
  • Market Cap
  • MDGL 6.8B
  • POST 6.2B
  • IPO Year
  • MDGL N/A
  • POST N/A
  • Fundamental
  • Price
  • MDGL $275.26
  • POST $110.67
  • Analyst Decision
  • MDGL Strong Buy
  • POST Buy
  • Analyst Count
  • MDGL 10
  • POST 6
  • Target Price
  • MDGL $420.63
  • POST $128.00
  • AVG Volume (30 Days)
  • MDGL 335.5K
  • POST 601.2K
  • Earning Date
  • MDGL 05-01-2025
  • POST 05-08-2025
  • Dividend Yield
  • MDGL N/A
  • POST N/A
  • EPS Growth
  • MDGL N/A
  • POST 8.42
  • EPS
  • MDGL N/A
  • POST 5.65
  • Revenue
  • MDGL $317,383,000.00
  • POST $7,884,600,000.00
  • Revenue This Year
  • MDGL $285.43
  • POST $2.14
  • Revenue Next Year
  • MDGL $63.77
  • POST $1.66
  • P/E Ratio
  • MDGL N/A
  • POST $19.58
  • Revenue Growth
  • MDGL N/A
  • POST 1.48
  • 52 Week Low
  • MDGL $200.63
  • POST $99.70
  • 52 Week High
  • MDGL $377.46
  • POST $125.84
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 38.56
  • POST 49.45
  • Support Level
  • MDGL $265.39
  • POST $108.48
  • Resistance Level
  • MDGL $275.54
  • POST $109.93
  • Average True Range (ATR)
  • MDGL 11.39
  • POST 1.89
  • MACD
  • MDGL -1.08
  • POST 0.17
  • Stochastic Oscillator
  • MDGL 24.12
  • POST 69.60

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About POST Post Holdings Inc.

Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.

Share on Social Networks: